摘要
中成药二次开发是一条投入少、见效快、创新驱动中药产业跨越发展的有效途径。该文围绕做大做强现代中药品种的目标,提出中成药二次开发理论及方法,简述为"1个目标、3项分析、5个明确及7方面提升";进而研究论述了中药大品种培育模式、制药技术升级改造路径及核心技术体系的构建方法。
Secondary development of Chinese Patent Medicine (CPM) is an effective and innovation-driven way for the leaping development of Chinese medicine industry with less investment and faster return. Aim to improving the efficacy, safety and batch-to- batch consistency of CPMs, the theory and methodology for the secondary development of CPMs, mode for cultivating superior CPM, approaches to reforming the pharmaceutical technology and the corresponding core technologies were proposed in this paper, which is summarized as 'One objective, Three analyses, Five definitudes and Seven improvements'.
出处
《中国中药杂志》
CAS
CSCD
北大核心
2013年第22期3797-3800,共4页
China Journal of Chinese Materia Medica
关键词
中药二次开发
系统工程
网络药理学
制药工艺品质
转化医学
secondary development of Chinese patent medicine
systems engineering
network pharmacology
pharmaceuticalprocess performance
translational medicine